医学研究公司Natera的收入估计数超过Q2,为413.35M美元,EPS为-0.30美元。 Medical research firm Natera surpassed Q2 revenue estimates with $413.35M and EPS of -$0.30.
医学研究公司Natera报告说,Q2收入高于预期,EPS收入为0.30美元,收入为413.35M美元,超过343MM美元。 Medical research firm Natera reported better-than-expected Q2 earnings, with EPS of -$0.30 and revenue of $413.35M, exceeding $343M estimates. 在5月15日中午交易期间,该公司的股票达到114.57美元。 The company's stock reached $114.57 during midday trading on May 15th. 首席执行官史蒂文·伦纳德·查普曼（Steven Leonard Chapman）出售了6,779股股票，而SG Americas Securities等机构投资者增加了对Natera的股份。 CEO Steven Leonard Chapman sold 6,779 shares, while institutional investors, like SG Americas Securities, have increased their stakes in Natera. 分析师对股票的看法不一, 评分从“持有”到“购买”不等。 Analysts have given mixed opinions on the stock, with ratings ranging from "hold" to "buy."